Literature DB >> 21660882

Estimating premorbid IQ in the prodromal phase of a neurodegenerative disease.

Noelle E Carlozzi1, Julie C Stout, James A Mills, Kevin Duff, Leigh J Beglinger, Elizabeth H Aylward, Kathryn B Whitlock, Andrea C Solomon, Sarah Queller, Douglas R Langbehn, Shannon A Johnson, Jane S Paulsen.   

Abstract

Estimates of premorbid intellect are often used in neuropsychological assessment to make inferences about cognitive decline. To optimize the method of controlling for premorbid intellect in assessments of prodromal neurodegenerative disease, we examined performance on the American National Adult Reading Test (ANART; administered during Years 1 and 3) and the two-subtest version of the Wechsler Abbreviated Scale of Intelligence (WASI; administered in Years 2 and 4) in an ongoing prospective longitudinal study of 371 participants with prodromal Huntington disease and 51 participants with normal CAG repeats. Although both measures performed similarly, the ANART demonstrated slightly lower variability in performance over a 2-year period and had slightly higher test-retest reliability than the WASI.

Entities:  

Mesh:

Year:  2011        PMID: 21660882      PMCID: PMC3159182          DOI: 10.1080/13854046.2011.577811

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  25 in total

1.  Estimation of WAIS-III intelligence from combined performance and demographic variables: development of the OPIE-3.

Authors:  Mike R Schoenberg; James G Scott; Kevin Duff; Russell L Adams
Journal:  Clin Neuropsychol       Date:  2002-12       Impact factor: 3.535

2.  Neuropsychologists' practice patterns in assessing premorbid intelligence.

Authors:  L Smith-Seemiller; M D Franzen; E J Burgess; L R Prieto
Journal:  Arch Clin Neuropsychol       Date:  1997-11       Impact factor: 2.813

3.  Determining neuropsychological impairment using estimates of premorbid intelligence: comparing methods based on level of education versus reading scores.

Authors:  B Johnstone; J Slaughter; L Schopp; J A McAllister; C Schwake; A Luebbering
Journal:  Arch Clin Neuropsychol       Date:  1997       Impact factor: 2.813

4.  The National Adult Reading Test as a measure of premorbid intelligence: a comparison with estimates derived from demographic variables.

Authors:  Peter Bright; Eli Jaldow; Michael D Kopelman
Journal:  J Int Neuropsychol Soc       Date:  2002-09       Impact factor: 2.892

5.  A longitudinal study of reading ability in patients suffering from dementia.

Authors:  L Paque; E K Warrington
Journal:  J Int Neuropsychol Soc       Date:  1995-11       Impact factor: 2.892

6.  Mild cognitive impairment in prediagnosed Huntington disease.

Authors:  K Duff; J Paulsen; J Mills; L J Beglinger; D J Moser; M M Smith; D Langbehn; J Stout; S Queller; D L Harrington
Journal:  Neurology       Date:  2010-07-07       Impact factor: 9.910

7.  Visuospatial impairment in Parkinson's disease.

Authors:  B E Levin; M M Llabre; S Reisman; W J Weiner; J Sanchez-Ramos; C Singer; M C Brown
Journal:  Neurology       Date:  1991-03       Impact factor: 9.910

8.  Progressive decline in NART score with increasing dementia severity.

Authors:  J Cockburn; J Keene; T Hope; P Smith
Journal:  J Clin Exp Neuropsychol       Date:  2000-08       Impact factor: 2.475

9.  Reluctance to undergo predictive testing: the case of Huntington disease.

Authors:  K A Quaid; M Morris
Journal:  Am J Med Genet       Date:  1993-01-01

10.  A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length.

Authors:  D R Langbehn; R R Brinkman; D Falush; J S Paulsen; M R Hayden
Journal:  Clin Genet       Date:  2004-04       Impact factor: 4.438

View more
  6 in total

Review 1.  Cognitive impairment in Huntington disease: diagnosis and treatment.

Authors:  Jane S Paulsen
Journal:  Curr Neurol Neurosci Rep       Date:  2011-10       Impact factor: 5.081

2.  Emergence of mild cognitive impairment in late middle-aged adults in the wisconsin registry for Alzheimer's prevention.

Authors:  Rebecca L Koscik; Asenath La Rue; Erin M Jonaitis; Ozioma C Okonkwo; Sterling C Johnson; Barbara B Bendlin; Bruce P Hermann; Mark A Sager
Journal:  Dement Geriatr Cogn Disord       Date:  2014-02-20       Impact factor: 2.959

3.  Cognitive reserve and brain reserve in prodromal Huntington's disease.

Authors:  Aaron Bonner-Jackson; Jeffrey D Long; Holly Westervelt; Geoffrey Tremont; Elizabeth Aylward; Jane S Paulsen
Journal:  J Int Neuropsychol Soc       Date:  2013-05-23       Impact factor: 2.892

4.  Electrophysiological, cognitive and clinical profiles of at-risk mental state: The longitudinal Minds in Transition (MinT) study.

Authors:  Rebbekah J Atkinson; W Ross Fulham; Patricia T Michie; Philip B Ward; Juanita Todd; Helen Stain; Robyn Langdon; Renate Thienel; Georgie Paulik; Gavin Cooper; Ulrich Schall
Journal:  PLoS One       Date:  2017-02-10       Impact factor: 3.240

Review 5.  Cognitive-Motor Interference in Neurodegenerative Disease: A Narrative Review and Implications for Clinical Management.

Authors:  Tara L McIsaac; Nora E Fritz; Lori Quinn; Lisa M Muratori
Journal:  Front Psychol       Date:  2018-10-29

6.  Self-Reported Hearing Loss and Longitudinal Cognitive Function in a Cohort Enriched with Risk for Alzheimer's Disease.

Authors:  Taylor N Fields; Kimberly D Mueller; Rebecca L Koscik; Sterling C Johnson; Ozioma C Okonkwo; Ruth Y Litovsky
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.160

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.